| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... Cell 155 (2), 462-477, 2013 | 2997 | 2013 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1081 | 2016 |
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice EC Holland, J Celestino, C Dai, L Schaefer, RE Sawaya, GN Fuller Nature genetics 25 (1), 55-57, 2000 | 1012 | 2000 |
| PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo C Dai, JC Celestino, Y Okada, DN Louis, GN Fuller, EC Holland Genes & development 15 (15), 1913-1925, 2001 | 743 | 2001 |
| Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment AJ Kumar, NE Leeds, GN Fuller, P Van Tassel, MH Maor, RE Sawaya, ... Radiology 217 (2), 377-384, 2000 | 638 | 2000 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 497 | 2014 |
| Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice JF De Groot, G Fuller, AJ Kumar, Y Piao, K Eterovic, Y Ji, CA Conrad Neuro-oncology 12 (3), 233-242, 2010 | 483 | 2010 |
| Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results FF Lang, JM Bruner, GN Fuller, K Aldape, MD Prados, S Chang, ... Journal of Clinical Oncology 21 (13), 2508-2518, 2003 | 425 | 2003 |
| Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ... Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990 | 425 | 1990 |
| Sacral chordoma: 40-year experience at a major cancer center JE York, A Kaczaraj, D Abi-Said, GN Fuller, JM Skibber, NA Janjan, ... Neurosurgery 44 (1), 74-79, 1999 | 406 | 1999 |
| Limitations of stereotactic biopsy in the initial management of gliomas RJ Jackson, GN Fuller, D Abi-Said, FF Lang, ZL Gokaslan, WM Shi, ... Neuro-oncology 3 (3), 193-200, 2001 | 397 | 2001 |
| A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors LL Chen, JC Trent, EF Wu, GN Fuller, L Ramdas, W Zhang, AK Raymond, ... Cancer research 64 (17), 5913-5919, 2004 | 374 | 2004 |
| Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro M Yamamoto, S Mohanam, R Sawaya, GN Fuller, M Seiki, H Sato, ... Cancer Research 56 (2), 384-392, 1996 | 348 | 1996 |
| Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt L Uhrbom, C Dai, JC Celestino, MK Rosenblum, GN Fuller, EC Holland Cancer research 62 (19), 5551-5558, 2002 | 330 | 2002 |
| PD-L1 expression and prognostic impact in glioblastoma EK Nduom, J Wei, NK Yaghi, N Huang, LY Kong, K Gabrusiewicz, X Ling, ... Neuro-oncology 18 (2), 195-205, 2015 | 310 | 2015 |
| Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway J Fueyo, R Alemany, C Gomez-Manzano, GN Fuller, A Khan, CA Conrad, ... Journal of the National Cancer Institute 95 (9), 652-660, 2003 | 304 | 2003 |
| RET oncogene activation in papillary thyroid carcinoma G Tallini, SL Asa, GN Fuller Advances in anatomic pathology 8 (6), 345-354, 2001 | 275 | 2001 |
| Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling GN Fuller, CH Rhee, KR Hess, LS Caskey, R Wang, JM Bruner, ... Cancer research 59 (17), 4228-4232, 1999 | 264 | 1999 |
| The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series LE Ginsberg, GN Fuller, M Hashmi, NE Leeds, DF Schomer Surgical neurology 49 (4), 436-440, 1998 | 260 | 1998 |
| Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas AB Heimberger, M Abou-Ghazal, C Reina-Ortiz, DS Yang, W Sun, W Qiao, ... Clinical Cancer Research 14 (16), 5166-5172, 2008 | 258 | 2008 |
Wei Zhang PhD, Professor of Cancer...The Comprehensive Cancer Center of Wake Forest Baptist Medical CenterBestätigte E-Mail-Adresse bei wakehealth.edu
